Keymed Biosciences Announces 2023 Annual Results and Business Updates

CHENGDU, China, March 27, 2024 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) today announced its 2023 annual results, along with recent

Related Keywords

Chengdu ,Sichuan ,China ,Thailand ,United States ,American ,Keymed Biosciences ,Bo Chen ,American Society Of Hematology ,Astrazeneca ,Keymed Biosciences Inc ,European Hematology Association ,American Society Of Clinical Oncology ,Hong Kong Stock Exchange On ,New Drug Application ,Executive Director ,Chief Executive Officer ,American Society ,Clinical Oncology ,Hong Kong Stock Exchange ,Keymed Biosciences Announces ,Thailand Business ,